Randomized Study of Basal-Bolus Insulin Therapy in the Inpatient Management of Patients With Type 2 Diabetes Undergoing General Surgery (RABBIT 2 Surgery)
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The optimal treatment of hyperglycemia in general surgical patients with type 2 diabetes mellitus is not known. RESEARCH DESIGN AND METHODS: This randomized multicenter trial compared the safety and efficacy of a basal-bolus insulin regimen with glargine once daily and glulisine before meals (n = 104) to sliding scale regular insulin (SSI) four times daily (n = 107) in patients with type 2 diabetes mellitus undergoing general surgery. Outcomes included differences in daily blood glucose (BG) and a composite of postoperative complications including wound infection, pneumonia, bacteremia, and respiratory and acute renal failure. RESULTS: The mean daily glucose concentration after the 1st day of basal-bolus insulin and SSI was 145 ± 32 mg/dL and 172 ± 47 mg/dL, respectively (P < 0.01). Glucose readings <140 mg/dL were recorded in 55% of patients in basal-bolus and 31% in the SSI group (P < 0.001). There were reductions with basal-bolus as compared with SSI in the composite outcome [24.3 and 8.6%; odds ratio 3.39 (95% CI 1.50–7.65); P = 0.003]. Glucose <70 mg/dL was reported in 23.1% of patients in the basal-bolus group and 4.7% in the SSI group (P < 0.001), but there were no significant differences in the frequency of BG <40 mg/dL between groups (P = 0.057). CONCLUSIONS: Basal-bolus treatment with glargine once daily plus glulisine before meals improved glycemic control and reduced hospital complications compared with SSI in general surgery patients. Our study indicates that a basal-bolus insulin regimen is preferred over SSI in the hospital management of general surgery patients with type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As discussed in Q12. How can glycemic targets be achieved in persons with T2D? as well as in the AACE Comprehensive Type 2 Diabetes Management Algorithm,73 some newer therapies carry a lower risk of hypoglycemia, which may enable more persons to safely achieve individualized target A1C levels.69,88–90”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [90]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“A randomized controlled trial has shown that basal plus bolus insulin plan improved glycemic outcomes and reduced hospital complications compared with a correction or supplemental insulin without basal insulin (formerly known as sliding scale) for people with type 2 diabetes admitted for general surgery (74).”
From 16. Diabetes Care in the Hospital: Standards of Care in Diabetes—2026 (2026) · cites this paper as [74]
The cited source says what the claim attributes to it.
In the citing paper
“In individuals undergoing noncardiac general surgery, basal insulin plus premeal short-or rapid-acting insulin (basal-bolus) coverage has been associated with improved glycemic outcomes and lower rates of perioperative complications compared with the reactive, correction-only short-or rapid-acting insulin coverage alone with no basal insulin dosing (74,145).”
From 16. Diabetes Care in the Hospital: Standards of Care in Diabetes—2026 (2026) · cites this paper as [74]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Intensive glucose control (A1C levels <7% in T2D and <7.5% in T1D) in several clinical trials was found to reduce the risk of incident albuminuria (A2) and DKD onset.70,78,90,406–410”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [90]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977
Intensive insulin therapy in the medical ICU
Van den Berghe, G., Wilmer, A., Hermans, G., Meersseman, W., Wouters, P. J., Milants, I., Van Wijngaerden, E., Bobbaers, H., & Bouillon, R. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052521 · Cited by 3,639 · cited 1×
“…setting, observational and prospective clinical trials have shown that hyper-glycemia is associated with increased rates of hospital complications and mortality (8,10,11) and that improved glycemic control reduces multiorgan failure, systemic infections, and short-and long-term mortality (7,8).”
BackgroundHyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes
Umpierrez, G. E., Isaacs, S. D., Bazargan, N., You, X., Thaler, L. M., & Kitabchi, A. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8341 · Cited by 2,195
Self-citationManagement of diabetes and hyperglycemia in hospitals.
Clement, S., Braithwaite, S. S., Magee, M. F., Ahmann, A., Smith, E. P., Schafer, R. G., Hirsch, I. B., & on behalf of the Diabetes in Hospitals Writing Committee (2004) · Diabetes Care · doi:10.2337/diacare.27.2.553 · Cited by 1,266
Furnary, A. P., Gao, G., Grunkemeier, G. L., Wu, Y., Zerr, K. J., Bookin, S. O., Floten, H. S., & Starr, A. (2003) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1067/mtc.2003.181 · Cited by 1,130
Lazar, H. L., Chipkin, S. R., Fitzgerald, C. A., Bao, Y., Cabral, H., & Apstein, C. S. (2004) · Circulation · doi:10.1161/01.cir.0000121747.71054.79 · Cited by 717
Early Postoperative Glucose Control Predicts Nosocomial Infection Rate in Diabetic Patients
Pomposelli, J. J., Baxter, J. K., Babineau, T. J., Pomfret, E. A., Driscoll, D. F., Forse, R. A., & Bistrian, B. R. (1998) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/014860719802200277 · Cited by 700 · cited 2×
“7 times increased rate of infection (13).”
BackgroundUmpierrez, G. E., Smiley, D., Zisman, A., Prieto, L. M., Palacio, A., Ceron, M., Puig, A., & Mejia, R. (2007) · Diabetes Care · doi:10.2337/dc07-0295 · Cited by 671
Self-citationHyperglycemic Crises in Adult Patients With Diabetes
Kitabchi, A. E., Umpierrez, G. E., Murphy, M. B., & Kreisberg, R. A. (2006) · Diabetes Care · doi:10.2337/dc06-9916 · Cited by 512
Self-citationManagement of Hyperglycemia in the Hospital Setting
Inzucchi, S. E. (2006) · New England Journal of Medicine · doi:10.1056/nejmcp060094 · Cited by 391
Cited by
Items 101–200 of 733
Pasquel, F. J., Fayfman, M., & Umpierrez, G. E. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1184-8 · Cited by 60
Self-citationPerioperative glycemic management in adults presenting for elective cardiac and non-cardiac surgery
Sreedharan, R., Khanna, S. K., & Shaw, A. (2023) · Perioperative Medicine · doi:10.1186/s13741-023-00302-6 · Cited by 70
“Long-acting basal insulin with or without prandial insulin is recommended to attain the goal and minimize variability (Umpierrez et al. 2013; Umpierrez et al. 2011).”
BackgroundHyperglycemia and Acute Kidney Injury During the Perioperative Period
Mendez, C. E., Mesropian, P. J. D., Mathew, R. O., & Slawski, B. A. (2016) · Current Diabetes Reports · doi:10.1007/s11892-015-0701-7 · Cited by 59
“…year Patient population No. of patients Design Renal measurements Major findings (intensive glycemic control as compared to controls) Umpierrez et al. 2011 [81••] Diabetic general surgery patients 211 RCT: basal-bolus insulin regimen vs. sliding scale insulin (SSI) AKI defined as…”
BackgroundBueno, E., Benitez, A., Rufinelli, J., Figueredo, R., Alsina, S., Ojeda, A., Samudio, S., Cáceres, M., Argüello, R., Romero, F., et al. (2015) · Endocrine Practice · doi:10.4158/ep15675.or · Cited by 56
Self-citationHerzig, D., Suhner, S., Roos, J., Schürch, D., Cecchini, L., Nakas, C. T., Weiss, S., Kadner, A., Kocher, G. J., Guensch, D. P., et al. (2022) · Diabetes Care · doi:10.2337/dc22-0438 · Cited by 64
Newton, C. A., Adeel, S., Sadeghi-Yarandi, S., Powell, W., Migdal, A. L., Smiley, D. D., Olson, D. E., Chambria, R., Pinzon, I., Toyoshima, M. T. K., et al. (2013) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2013.08.001 · Cited by 61
Self-citationPasquel, F. J., Gomez-Huelgas, R., Anzola, I., Oyedokun, F., Haw, J. S., Vellanki, P., Peng, L., & Umpierrez, G. E. (2015) · Diabetes Care · doi:10.2337/dc15-1835 · Cited by 55
Self-citationIn-hospital management of diabetes
Malcolm, J., Halperin, I., Miller, D. B., Moore, S., Nerenberg, K. A., Woo, V., & Yu, C. H. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.10.014 · Cited by 55
Demma, L. J., Carlson, K. T., Duggan, E. W., Morrow, J. G., & Umpierrez, G. (2017) · Journal of Clinical Anesthesia · doi:10.1016/j.jclinane.2016.10.003 · Cited by 55
Self-citationInitial Management of Septic Patients with Hyperglycemia in the Noncritical Care Inpatient Setting
Schüetz, P., Kennedy, M., Lucas, J. M., Howell, M. D., Aird, W. C., Yealy, D. M., & Shapiro, N. I. (2012) · The American Journal of Medicine · doi:10.1016/j.amjmed.2012.03.001 · Cited by 55
“9) Female gender, n (%) 883 (48) Race, n (%) White 1408 (76) African American 252 (14) Asian 51 (3) Other 138 (7) omorbidities, n (%) Coronary artery disease 135 (7) Congestive heart failure 209 (11) Cerebrovascular disease 145 (8) Chronic obstructive pulmonary disease 229 (12) Dementia 111 (6) Chronic kidney disease…”
BackgroundTripyla, A., Herzig, D., Joachim, D., Nakas, C. T., Amiet, F., Andreou, A., Gloor, B., Vogt, A., & Bally, L. (2020) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14073 · Cited by 52
Donsa, K., Spat, S., Beck, P., Pieber, T. R., & Holzinger, A. (2015) · Lecture notes in computer science · doi:10.1007/978-3-319-16226-3_10 · Cited by 60
Neubauer, K. M., Mader, J. K., Höll, B., Aberer, F., Donsa, K., Augustin, T., Schaupp, L., Spat, S., Beck, P., Fruhwald, F. M., et al. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2015.0027 · Cited by 51
“Admission diagnosis [n (%)] — Hematological disease 1 (1) 1 (7) 0 (0) 0 (0) 0 (0) Gastrointestinal disease 1 (1) 1 (7) 0 (0) 0 (0) 0 (0) Endocrine disease 11 (11) 0 (0) 1 (3) 10 (24) 0 (0) Cardiovascular disease 44 (44) 4 (27) 29 (97) 11 (26) 0 (0) Neurological disease 1 (1) 1 (7) 0 (0) 0 (0) 0 (0) Infectious disease…”
Lee, Y.-Y., Lin, Y.-M., Leu, W.-J., Wu, M.-Y., Tseng, J.-H., Hsu, M.-T., Tsai, C.-S., Hsieh, A.-T., & Tam, K.-W. (2015) · Metabolism · doi:10.1016/j.metabol.2015.05.011 · Cited by 51
“The regular insulin sliding scale versus non-sliding-scale regimens Eight of the included studies compared the RISS with others regimens (Table 1).(4-9,25) The results of the meta-analysis are presented as follows:”
BackgroundResultfor the ProHOSP Study Group, Schüetz, P., Friedli, N., Grolimund, E., Kutz, A., Haubitz, S., Christ‐Crain, M., Thomann, R., Zimmerli, W., Hoess, C., et al. (2013) · Diabetologia · doi:10.1007/s00125-013-3112-9 · Cited by 55
“Finally, unlike other investigations, such as the RABBIT 2 surgery trial [50], we did not find any evidence for effect modification of insulin treatment on the association of glucose and clinical outcome, or biomarker levels.”
ResultTransition From Intravenous to Subcutaneous Insulin
Avanzini, F., Marelli, G., Donzelli, W., Busi, G., Carbone, S., Bellato, L., Colombo, E. L., Foschi, R., Riva, E., Roncaglioni, M. C., et al. (2011) · Diabetes Care · doi:10.2337/dc10-2023 · Cited by 50
“In the RABBIT 2 Surgery trial on general surgery patients, the mean daily BG was 1576 32 mg/dL in subjects randomized to glargine and glulisine and the proportion of BG values,140 mg/dL was 536 30% (18).”
BackgroundRadhakutty, A., & Burt, M. G. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0315 · Cited by 50
Impact of Hypoglycemia in Hospitalized Patients
Carey, M., Boucai, L., & Zonszein, J. (2012) · Current Diabetes Reports · doi:10.1007/s11892-012-0336-x · Cited by 56
Recent advances in diabetes treatments and their perioperative implications
Kuzulugil, D., Papeix, G., Luu, J., & Kerridge, R. K. (2019) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0000000000000735 · Cited by 52
Is Incretin-Based Therapy Ready for the Care of Hospitalized Patients With Type 2 Diabetes?
Umpierrez, G. E., & Korytkowski, M. (2013) · Diabetes Care · doi:10.2337/dc12-2233 · Cited by 49
“Scheduled basalbolus SC insulin therapy consisting of long- or intermediate-acting preparations in combination with short- or rapid-acting analogs has been proven to be safe and effective for glycemic management and to reduce hospital complications including wound infections, pneumonia, bacteremia, and acute renal and…”
BackgroundSelf-citationPerioperative management of adult diabetic patients. Intraoperative period
Cheisson, G., Jacqueminet, S., Cosson, E., Ichaï, C., Leguerrier, A.-M., Catargi, B., Ouattara, A., Tauveron, I., Valensi, P. E., & Benhamou, D. (2018) · Anaesthesia Critical Care & Pain Medicine · doi:10.1016/j.accpm.2018.02.018 · Cited by 55
Perioperative Management of Diabetes Mellitus: Novel Approaches
Palermo, N. E., & Garg, R. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1132-7 · Cited by 52
Insulin Therapy in Hospitalized Patients
Pérez, A., Ramos, A., & Carreras, G. (2020) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000001078 · Cited by 45
Pharmacotherapy for Hyperglycemia in Noncritically Ill Hospitalized Patients
Mendez, C. E., & Umpierrez, G. E. (2014) · Diabetes Spectrum · doi:10.2337/diaspect.27.3.180 · Cited by 46
Self-citationOlsen, M. T., Klarskov, C. K., Jensen, S. H., Rasmussen, L. M., Lindegaard, B., Andersen, J. A., Gottlieb, H., Lunding, S., Pedersen‐Bjergaard, U., Hansen, K. B., et al. (2025) · Diabetes Care · doi:10.2337/dc24-2222 · Cited by 47
Sliding scale insulin for non-critically ill hospitalised adults with diabetes mellitus
Colunga-Lozano, L. E., Gonzalez Torres, F. J., Delgado-Figueroa, N., Gonzalez-Padilla, D. A., Hernandez, A. V., Roman, Y., & Cuello-García, C. A. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011296.pub2 · Cited by 45
“Study or subgroup Sliding scale insulin Basal-bolus insulin Mean Difference Weight Mean Difference N Mean(SD) N Mean(SD) Random, 95% CI Random, 95% CI 1.6.1 Medical participants Korytkowski 2009 25 160 (29) 25 164 (29) 13.13% -4[-20.08,12.08] Said 2013 22 222 (67) 19 221 (67) 2.74% 1[-40.13,42.13] Umpierrez 2007a 65 1…”
BackgroundMethodResultInfluentialInpatient hyperglycemia management: A practical review for primary medical and surgical teams
Lansang, M. C., & Umpierrez, G. E. (2016) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.83.s1.06 · Cited by 50
Self-citationPasquel, F. J., Lansang, M. C., Khowaja, A., Urrutia, M. A., Cardona, S., Albury, B., Galindo, R. J., Fayfman, M., Davis, G., Migdal, A., et al. (2020) · Diabetes Care · doi:10.2337/dc19-1940 · Cited by 45
“The results of multiple clinical trials in the hospital setting suggest that patients with diabetes may respond differently to a commonly used basal-bolus approach (7,9,12,24,25,29).”
BackgroundMethodResultInfluentialSelf-citationRuiz de Adana, M. S., Colomo, N., Maldonado-Araque, C., Fontalba, M. I., Linares, F., García-Torres, F., Fernández, R., Bautista, C., Olveira, G., de la Cruz, J. L., et al. (2015) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.09.015 · Cited by 45
Enhanced perioperative care in emergency general surgery: the WSES position paper
Ceresoli, M., Braga, M., Zanini, N., Abu‐Zidan, F. M., Parini, D., Länger, T., Sartelli, M., Damaskos, D., Biffl, W. L., Amico, F., et al. (2023) · World Journal of Emergency Surgery · doi:10.1186/s13017-023-00519-2 · Cited by 48
“The correction of hyperglycemia with insulin administration and the management of glycemia with the implementation of glycaemic control protocols have been shown to reduce hospital complications and decreases mortality in elective general surgery patients [45].”
BackgroundUmpierrez, G. E., Cardona, S., Chachkhiani, D., Fayfman, M., Saiyed, S., Wang, H., Vellanki, P., Haw, J. S., Olson, D. E., Pasquel, F. J., et al. (2018) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2017.11.002 · Cited by 43
Self-citationRoberts, G. W., Aguilar‐Loza, N., Esterman, A., Burt, M. G., & Stranks, S. N. (2012) · Medical Journal of Australia · doi:10.5694/mja11.10853 · Cited by 42
Cardona, S., Gomez, P. C., Vellanki, P., Anzola, I., Ramos, C., Urrutia, M. A., Haw, J. S., Fayfman, M., Wang, H., Galindo, R. J., et al. (2018) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2018-000607 · Cited by 38
Self-citationGlycemic Control and Prevention of Surgical Site Infection
Kao, L. S., & Phatak, U. R. (2013) · Surgical Infections · doi:10.1089/sur.2013.008 · Cited by 46
“In a randomized trial using sliding scale regular insulin to achieve a target of 100 to 140 mg/dL in non-critically ill general surgery patients, hypoglycemia < 70 mg/dL occurred in almost 5% of patients [81].”
Fushimi, N., Shibuya, T., Yoshida, Y., Ito, S., Hachiya, H., & Mori, A. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13093 · Cited by 41
Rajendran, R., Kerry, C., Rayman, G. A., & on behalf of the MaGIC study group (2014) · BMJ Open · doi:10.1136/bmjopen-2014-005165 · Cited by 41
Jämsen, E., Nevalainen, P. I., Eskelinen, A. P., Kalliovalkama, J., & Moilanen, T. P. S. (2014) · Acta Orthopaedica · doi:10.3109/17453674.2014.987064 · Cited by 43
“…should be acknowledged that in these studies as well as in ours, hyperglycemia was first treated after it had occurred (insulin was administered on a so-called sliding scale basis), which leads to inferior outcomes compared to treatment with long-acting basal-bolus insulin (Umpierrez et al. 2011).”
ResultAloi, J., Bode, B. W., Ullal, J., Chidester, P., McFarland, R. S., Bedingfield, A. E., Mabrey, M., Booth, R., Mumpower, A., & Wallia, A. (2017) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816664746 · Cited by 39
Duggan, E. W., Klopman, M. A., Berry, A. J., & Umpierrez, G. E. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0720-z · Cited by 39
Self-citationBrady, V., Thosani, S., Zhou, S., Bassett, R., Busaidy, N. L., & Lavis, V. (2014) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0115 · Cited by 39
Rudy, M. D., Ahuja, N. K., & Aaronson, A. J. (2018) · JBJS Reviews · doi:10.2106/jbjs.rvw.17.00146 · Cited by 39
Burt, M. G., Drake, S. M., Aguilar‐Loza, N. R., Esterman, A., Stranks, S. N., & Roberts, G. W. (2015) · Internal Medicine Journal · doi:10.1111/imj.12680 · Cited by 38
Radhakutty, A., Stranks, J. L., Mangelsdorf, B. L., Drake, S. M., Roberts, G. W., Zimmermann, A. T., Stranks, S. N., Thompson, C. H., & Burt, M. G. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12859 · Cited by 38
“Treatment of hyperglycaemia has been reported to reduce morbidity in hospitalized patients.(10,11) The Endocrine Society clinical practice guidelines and the American Diabetes Association standards of medical care in diabetes recommend prescribing insulin Received: 30 November 2016 Revised: 12 December 2016 Accepted:…”
BackgroundRecent advances in bariatric/metabolic surgery: appraisal of clinical evidence
Wei-Jei, L., & Abdullah, A. (2015) · Journal of Biomedical Research · doi:10.7555/jbr.28.20140120 · Cited by 44
“The reason for the more severe complication in T2DM patients might be related to the compromised cardiovascular system and depressed immunity in patients with poorly controlled diabetes [33,34] .”
BackgroundManagement of Hyperglycemia During the Perioperative Period
Pichardo-Lowden, A. R., & Gabbay, R. A. (2011) · Current Diabetes Reports · doi:10.1007/s11892-011-0239-2 · Cited by 39
Predictors of hypoglycemia in hospitalized patients with diabetes mellitus
Akirov, A., Amitai, O., Masri‐Iraqi, H., Diker‐Cohen, T., Shochat, T., Eizenberg, Y., & Shimon, I. (2018) · Internal and Emergency Medicine · doi:10.1007/s11739-018-1787-0 · Cited by 43
Okamura, A., Yamamoto, H., Watanabe, M., Miyata, H., Kanaji, S., Kamiya, K., Kakeji, Y., Doki, Y., & Kitagawa, Y. (2020) · Annals of Surgery · doi:10.1097/sla.0000000000004547 · Cited by 39
Pérez-Belmonte, L. M., Osuna-Sánchez, J., Millán-Gómez, M., López-Carmona, M. D., Gómez-Doblas, J. J., Cobos-Palacios, L., Sanz-Cánovas, J., Barbancho, M. A., Lara, J. P., Jiménez-Navarro, M., et al. (2019) · Annals of Medicine · doi:10.1080/07853890.2019.1613672 · Cited by 36
Vellanki, P., Bean, R., Oyedokun, F. A., Pasquel, F. J., Smiley, D., Farrokhi, F., Newton, C., Peng, L., & Umpierrez, G. E. (2015) · Diabetes Care · doi:10.2337/dc14-1796 · Cited by 36
Self-citationCheung, N. W., Wong, K. Y. C., Kovoor, P., & McLean, M. P. (2019) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2018.12.015 · Cited by 41
Mader, J. K., Neubauer, K. M., Schaupp, L., Augustin, T., Beck, P., Spat, S., Höll, B., Treiber, G. M., Fruhwald, F. M., Pieber, T. R., et al. (2014) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12186 · Cited by 36
“[10] and on a pretest chart review, which was conducted at the two wards [12].”
BackgroundDonsa, K., Beck, P., Höll, B., Mader, J. K., Schaupp, L. A., Plank, J., Neubauer, K. M., Baumgärtner, C., & Pieber, T. R. (2016) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2016.03.007 · Cited by 39
Inpatient Continuous Glucose Monitoring and Glycemic Outcomes
Levitt, D. L., Silver, K. D., & Spanakis, E. K. (2017) · Journal of Diabetes Science and Technology · doi:10.1177/1932296817698499 · Cited by 38
“Moreover, hypoglycemia is detected in up to 30% of Type 2 Diabetes Mellitus (T2DM) patients treated with subcutaneous insulin.(8,14-16) In the ICU, hypoglycemia occurs more often with intensive insulin therapy and is associated with increased mortality.”
BackgroundZelada, H., Perez‐Guzman, M. C., Cherñavvsky, D. R., & Galindo, R. J. (2023) · Endocrine Connections · doi:10.1530/ec-23-0180 · Cited by 36
Pérez-Belmonte, L., Gómez-Doblas, J., Millán-Gómez, M., López-Carmona, M., Guijarro-Merino, R., Carrasco-Chinchilla, F., De Teresa-Galván, E., Jiménez-Navarro, M., Bernal-López, M., & Gómez-Huelgas, R. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7090271 · Cited by 34
“The use of subcutaneous basal-bolus regimen, which involves the administration of a daily basal insulin dose and rapid-acting insulin before meals, has resulted in improved glycaemic control and reduced risk of complications in the hospital setting [9,10].”
BackgroundSato, H., Hosojima, M., Ishikawa, T., Aoki, K., Okamoto, T., Saito, A., & Tsuchida, M. (2017) · Annals of Thoracic and Cardiovascular Surgery · doi:10.5761/atcs.oa.17-00045 · Cited by 38
Barmanray, R., Kyi, M., Colman, P. G., Rowan, L. M., Raviskanthan, M., Collins, L., Donaldson, L., Montalto, S., Tsan, J., Sun, E., et al. (2024) · Diabetes Care · doi:10.2337/dc23-1905 · Cited by 34
Galindo, R. J., Dhatariya, K., Peralta, F. G., & Umpierrez, G. E. (2022) · Current Diabetes Reports · doi:10.1007/s11892-022-01464-1 · Cited by 36
Self-citationThe Place for Glycemic Control in the Surgical Patient
May, A. K., Kauffmann, R. M., & Collier, B. R. (2011) · Surgical Infections · doi:10.1089/sur.2011.019 · Cited by 37
Hospital management of hyperglycemia
Lleva, R. R., & Inzucchi, S. E. (2011) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e3283447a6d · Cited by 35
How do I manage hyperglycemia/post-transplant diabetes mellitus after allogeneic HSCT
Fuji, S., Rovó, A., Ohashi, K., Griffith, M., Einsele, H., Kapp, M., Mohty, M., Majhail, N. S., Engelhardt, B. G., Tichelli, A., et al. (2016) · Bone Marrow Transplantation · doi:10.1038/bmt.2016.81 · Cited by 35
Asche, C. V., Bode, B. W., Busk, A. K., & Nair, S. R. (2011) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01487.x · Cited by 34
“Furthermore, insulin treatment was found to be effective in the management of general surgery in people with T2DM [81].”
BackgroundSingh, L. G., Levitt, D. L., Satyarengga, M., Pinault, L. F., Zhan, M., Sorkin, J. D., Fink, J. C., Umpierrez, G. E., & Spanakis, E. K. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819889640 · Cited by 36
“Previous studies have reported prevalence of hypoglycemia in hospitalized insulin-treated DM patients ranging from 19% to 26%.(15,19,20) As these estimates are based on point-of-care (POC) glucose monitoring, true prevalence is likely greater given the infrequency of testing, typically occurring no more than four to s…”
BackgroundSelf-citationSobel, S. I., Augustine, M., Donihi, A. C., Reider, J. A., Forte, P. J., & Korytkowski, M. T. (2015) · Endocrine Practice · doi:10.4158/ep15727.or · Cited by 32
“However, this practice has the potential to cause postoperative hyperglycemia in individuals with type 1 DM who may be without insulin for periods of 2 or more hours, increasing risk for adverse postsurgical outcomes as described in previous studies (7,9,10,26).”
BackgroundMularski, K., Yeh, C. P., Bains, J. K., Mosen, D. M., Hill, A. K., & Mularski, R. A. (2012) · The Permanente Journal · doi:10.7812/tpp/11-131 · Cited by 36
“including wound infection, pneumonia, bacteremia, respiratory failure, and acute renal failure.(18) Unfortunately, patients admitted to hospitals primarily for surgical services may not have optimal attention paid to glycemic control.”
BackgroundPeled, S., Pollack, R. M., Elishoov, O., Haze, A., & Cahn, A. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00774 · Cited by 32
Gómez, A. M., Henao, D. C., Múñoz, Ó., Aschner, P. J., Yepes, C. A., Jojoa, R. I. J., Kerguelen, A., Parra, D., Jaramillo, P., & Umpierrez, G. E. (2021) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2021.02.008 · Cited by 31
“Several randomized controlled trials have reported that treatment with a basal-bolus regimen results in significantly lower mean daily blood glucose (BG) with a higher percentage of BG within target range in patients with type 2 diabetes [10,11].”
Self-citationPrice, C. E., Fanelli, J. E., Aloi, J., Anzola, S. C., Vishneski, S. R., Saha, A. K., Woody, C., & Segal, S. (2023) · Journal of Clinical Anesthesia · doi:10.1016/j.jclinane.2023.111090 · Cited by 32
Coan, K. E., Schlinkert, A. B., Beck, B. R., Haakinson, D. J., Castro, J. C., Apsey, H. A., Schlinkert, R. T., & Cook, C. B. (2013) · Journal of Diabetes Science and Technology · doi:10.1177/193229681300700410 · Cited by 31
Preoperative glucose as a screening tool in patients without diabetes
Wang, R., Panizales, M. T. P., Hudson, M., Rogers, S. O., & Schnipper, J. L. (2013) · Journal of Surgical Research · doi:10.1016/j.jss.2013.09.014 · Cited by 35
Hulst, A. H., Polderman, J. A. W., Ouweneel, E., Pijl, A. J., Hollmann, M. W., DeVries, J. H., Preckel, B., & Hermanides, J. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13118 · Cited by 31
Pichardo-Lowden, A., Umpierrez, G., Lehman, E. B., Bolton, M. D., DeFlitch, C. J., Chinchilli, V. M., & Haidet, P. M. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001557 · Cited by 30
“37 Basal-bolus insulin therapy is the standard of care for patients with type 1 diabetes, and SSI monotherapy is contraindicated in patients with type 1 diabetes due to their absolute insulin dependency and risk for diabetic ketoacidosis.”
BackgroundSelf-citationBarmanray, R., Kyi, M., Worth, L. J., Colman, P. G., Churilov, L. P., Fazio, T. N., Rayman, G. A., Gonzalez, V., Hall, C., & Fourlanos, S. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae051 · Cited by 33
Enhanced Recovery After Surgery (ERAS®) in Individuals with Diabetes: A Systematic Review
Albalawi, Z., Laffin, M., Gramlich, L. M., Senior, P. A., & McAlister, F. A. (2017) · World Journal of Surgery · doi:10.1007/s00268-017-3982-y · Cited by 32
Approach to the adult hospitalized patient on an insulin pump
Lansang, M. C., Modic, M. B., Sauvey, R., Lock, P., Ross, D., Combs, P., & Kennedy, L. (2013) · Journal of Hospital Medicine · doi:10.1002/jhm.2109 · Cited by 30
Mackey, P., Boyle, M. E., Walo, P. M., Castro, J. C., Cheng, M.-R., & Cook, C. B. (2013) · Endocrine Practice · doi:10.4158/ep13201.or · Cited by 32
Technology in the management of diabetes in hospitalised adults
Thabit, H., & Schofield, J. D. (2024) · Diabetologia · doi:10.1007/s00125-024-06206-4 · Cited by 34
Diabetes, dysglycemia, and vascular surgery
Duwayri, Y. M., & Jordan, W. D. (2019) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2019.05.027 · Cited by 31
González, C. L., Atienza, E., Reyes-Umpierrez, D., Vellanki, P., Davis, G. M., Pasquel, F. J., Cardona, S., Fayfman, M., Peng, L., & Umpierrez, G. E. (2020) · Endocrine Practice · doi:10.4158/ep-2019-0481 · Cited by 30
Self-citationPreoperative optimization for patients undergoing elective spine surgery
Wang, T. Y., Price, M. J., Mehta, V. A., Bergin, S. M., Sankey, E. W., Foster, N. A., Erickson, M. M., Gupta, D. K., Gottfried, O. N., Karikari, I. O., et al. (2021) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2020.106445 · Cited by 32
The Queensland Inpatient Diabetes Survey (QuIDS) 2019: the bedside audit of practice
Donovan, P. J., Eccles‐Smith, J., Hinton, N., Cutmore, C., Porter, K., Abel, J., Allam, L., Dermedgoglou, A., & Puri, G. (2021) · The Medical Journal of Australia · doi:10.5694/mja2.51048 · Cited by 30
Dombrowski, N. C., & Karounos, D. G. (2012) · Metabolism · doi:10.1016/j.metabol.2012.07.020 · Cited by 31
“This study indicates that a basal-bolus insulin regimen is preferred over SSI in the hospital management of general surgery patients with type 2 diabetes [52]”
Hakeam, H. A., Mulia, H. A., Azzam, A. Z., & Amin, T. M. (2016) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607116644710 · Cited by 29
Bain, A., Hasan, S. S., & Babar, Z. (2019) · Diabetic Medicine · doi:10.1111/dme.13982 · Cited by 30
Migdal, A. L., Fortin‐Leung, C., Pasquel, F., Wang, H., Peng, L., & Umpierrez, G. E. (2021) · Journal of Hospital Medicine · doi:10.12788/jhm.3654 · Cited by 28
Self-citationSpat, S., Donsa, K., Beck, P., Höll, B., Mader, J. K., Schaupp, L. A., Augustin, T., Chiarugi, F., Lichtenegger, K. M., Plank, J., et al. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816676501 · Cited by 29
Overcoming Clinical Inertia in the Management of Postoperative Patients with Diabetes
Apsey, H. A., Coan, K. E., Castro, J. C., Jameson, K. A., Schlinkert, R. T., & Cook, C. B. (2013) · Endocrine Practice · doi:10.4158/ep13366.or · Cited by 28
Inpatient Diabetes Management in the Twenty-First Century
Khazai, N. B., & Hamdy, O. (2016) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2016.06.013 · Cited by 32
Gallagher, J. M., Erich, R. A., Gattermeyer, R., & Beam, K. K. (2017) · JBJS Open Access · doi:10.2106/jbjs.oa.16.00008 · Cited by 27
Pérez, A., Reales, P., Barahona, M. J., Romero, M. G., Miñambres, I., & the HOSMIDIA Study Group (2014) · International Journal of Clinical Practice · doi:10.1111/ijcp.12498 · Cited by 30
Galindo, R. J., Pasquel, F. J., Vellanki, P., Alicic, R., Lam, D. W., Fayfman, M., Migdal, A. L., Davis, G. M., Cardona, S., Urrutia, M. A., et al. (2022) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14544 · Cited by 26
Self-citationPandya, N., Wei, W., Meyers, J., Kilpatrick, B. S., & Davis, K. L. (2013) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12547 · Cited by 26
Nursing Perspectives on the Use of Continuous Glucose Monitoring in the Intensive Care Unit
Faulds, E. R., Dungan, K. M., McNett, M., JONES, L. G., Poindexter, N., Exline, M. C., Pattison, J., & Pasquel, F. J. (2023) · Journal of Diabetes Science and Technology · doi:10.1177/19322968231170616 · Cited by 26
Oghazian, M. B., Javadi, M. R., Radfar, M., Torkamandi, H., Sadeghi, M., Hayatshahi, A., & Gholami, K. (2015) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1546 · Cited by 28
Inpatient Hypoglycemia: A Challenge That Must Be Addressed
Eiland, L. A., Goldner, W. S., Drincic, A., & Desouza, C. V. (2013) · Current Diabetes Reports · doi:10.1007/s11892-013-0445-1 · Cited by 27
The impact of glycaemic variability on the surgical patient
Dhatariya, K., Levy, N., & Hall, G. (2016) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0000000000000326 · Cited by 31
Perioperative Hyperglycemia: A Literature Review
Peacock, T. S. (2018) · AORN Journal · doi:10.1002/aorn.12445 · Cited by 28
Chen, E. B., Nooromid, M. J., Helenowski, I., Soper, N. J., & Halverson, A. L. (2019) · Surgery · doi:10.1016/j.surg.2019.04.043 · Cited by 27
Rubin, D. J., & Golden, S. H. (2013) · Hospital Practice · doi:10.3810/hp.2013.02.1016 · Cited by 28
Inpatient Hyperglycemia Management and COVID-19
Bellido, V., & Pérez, A. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00966-z · Cited by 27
“Randomized clinical trials have shown that basal-bolus treatment improves glycemic control and reduces the rate of hospital complications compared with reactive, or sliding-scale, insulin regimens [8, 52].”
Background
Metadata
- Authors
- Umpierrez, G. E., Smiley, D., Jacobs, S., Peng, L., Temponi, A., Mulligan, P., Umpierrez, D., Newton, C., Olson, D., & Rizzo, M.
- Affiliations
- Grady Memorial Hospital (US)
- Emory University (US)
- Department of Medicine, Emory University, Atlanta, Georgia
- Corresponding author
- Umpierrez, Guillermo E.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2011-01-20
- Volume
- 34
- Issue
- 2
- Pages
- 256-261
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3024330
- OpenAlex
- W2106327047
- Cited by
- 720
- References
- 24
- Citations by year
- 2026: 19 · 2025: 36 · 2024: 37 · 2023: 47 · 2022: 53 · 2021: 37 · 2020: 44 · 2019: 52 · 2018: 55 · 2017: 54 · 2016: 48 · 2015: 51 · 2014: 61 · 2013: 53 · 2012: 44
- FWCI
- 48.02
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (UL1TR000454)
- National Institute of Diabetes and Digestive and Kidney Diseases (R03DK073190)
- National Center for Research Resources (M01-RR00039, K12RR017643, M01RR000039)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- type 2 diabetes, multiple daily insulin injections, glargine, glulisine, sliding scale insulin, general surgery, perioperative hyperglycemia, glycemic control, postoperative complications, wound infection, respiratory failure, acute kidney injury, bacteremia
- MeSH terms
- Insulin Glargine, Aged, Blood Glucose, Diabetes Mellitus, Type 2, Female, Humans, Hypoglycemic Agents, Inpatients, Insulin, Male, Middle Aged, Postoperative Complications, Prospective Studies, General Surgery, Perioperative Care, Insulin, Long-Acting
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.